Heinrich Haas

Heinrich Haas

Company: BioNTech

Job title: Vice President, RNA Formulation & Drug Delivery


What’s Next? Next Generation LNPs to Support Novel Therapies With Collaboration 9:30 am

Translating research into reality – consideration for next gen LNP for other vaccines Strategies to improve particular technologies for next gen LNP Lessons learned so far to enhance our considerations during formulation and scale-up for LNP Leveraging pre-competitive collaboration to drive science forwardRead more

day: Day Two

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.